DEXMEDETOMIDINE HYDROCHLORIDE
| Brand name | DEXMEDETOMIDINE HYDROCHLORIDE |
|---|---|
| Active ingredient | DEXMEDETOMIDINE HYDROCHLORIDE |
| Strength | EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | June 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9717796 | April 2036 | product |
| 9649296 | April 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.